- Case report
- Open Access
Partial trisomy 13q22-qter associated to leukoencephalopathy and late onset generalised epilepsy
International Archives of Medicine volume 1, Article number: 5 (2008)
The partial trisomy 13q.22 is an uncommon chromosomopathy. We present a case with a partial trisomic component 13q22 and a monosomic component 5p15 from paternal origin. This patient developed early menopause and major neurological disorders as leukoencephalopathy, late onset generalised epilepsy and stroke. She also had fatty acids disturbances and their potential relation to the neurological disorders and early menopause is discussed. The presented case illustrates the phenotype of 13q22-qter in adult age and reaffirms the importance of studying the karyotype of any patient with seizures or leukoencephalopathy particularly when there are associated other clinical features including stroke at a young age, fatty acids disturbances, microcephaly, hypotelorism, short neck, hemangiomata, short fingers or distal swell in thumbs.
The partial trisomy 13 q is uncommon; its frequency has not been well determined. The few cases described in the medical literature recognised a specific phenotype, however, with extensive variability of expression. Major phenotypic features are: psychomotor retardation, frontal bossing, stubby nose, long philtrum and hemangiomata [1–3]. When the trisomy derives from segment q22 consistent findings are mental retardation, frontal bossing, long upwardly curved eyelashes, ears with small lobules and prominent antehelixes and hemangiomata. Other characteristics such as microcephaly, hypotelorism and hexadactyly, are usual but not constant. [4–8]. In patients with trisomy 13 syndrome holoprosencephaly appears in approximately 80% of cases, but callosal dysgenesis, hippocampal hypoplasia, olfatory hypoplasia, bilateral perisylvian and rolandic cortical dysplasia, vermian hypoplasia, dysplasia of the dentate nucleus have also been reported. The cases that survive often suffer seizures.
We report here a partial trisomy 13q22 case with prominent neurological disorders: leukoencephalopathy, late onset generalised epilepsy and stroke.
We present a 33 years old female, born after a normal pregnancy and delivery of non consanguineous parents. There was no family history of epilepsy. Her father suffers severe peripheral arteriopathy. Motor development was normal. At the age of 13 she dropped out of primary school due to learning disabilities. At age 29 she was menopausal. When she was 30 years old she suffered two isolated unexplained falls; later she suffered a generalised myoclonic seizure that was repeated three times during next eight months and at this point was attended at our hospital. Her phenotype included slight microcephaly and hypotelorism, short neck, small hemangiomata on face and back, android obesity and short fingers with distal swell in both thumbs (fig. 1). She had low IQ and hypoacusia. Abdominal echography showed splenomegaly. Blood tests showed hypochromic anaemia without other relevant abnormalities in haematology or biochemistry including normal renal and liver function. Total cholesterol, LDL-cholesterol and very long chain fatty acids (VLCFA) were also normal in blood. However 26:0/22:0 fatty acids were increased in mononuclear cells while 24:0 and 26:0 fatty acids were normal in fibroblasts. Total cholesterol in lymphocytes was low. Adrenoleukodystrophya-protein was negative in white blood cells. The electrocardiogram, echocardiography, carotid Doppler, conduction speeds and somatosensory evoked potentials were normal. T2 weighted MRI showed bilateral hyperintense lesions in white matter, predominantly in posterior regions (fig. 2A). EEG showed normal background activity with spike/wave and polyspikes generalised discharges that increased during NREM sleep (fig. 3). Visual evoked potential showed low amplitude and abnormal configuration. Brainstem auditive evoked potentials were abnormal with the wave V delayed and the waves I, II and III absent. She was put on valproic acid and EEGs were progressively normalizing.
She suddenly suffered left hemiplegia. MRI (Flair and T2 weighted and diffusion sequences) showed hyperintense signal in the right temporal cortex and subcortical area suggesting an ischemic stroke (fig 2B). Evaluation of the carotid bifurcation with magnetic resonance angiographic techniques showed stenosis (40% calibre) on the beginning of the right internal carotid artery. The hypercoagulability study showed moderate increase of the VIII factor. She was put on clopidogrel 75 mg. per day. During the three next years she only had a nocturnal seizure in relation with oversight of valproic acid intake. Eventually she suffered a nocturnal status epilepticus and died as a result. Unfortunately, the autopsy was not performed.
Cytogenic chromosome analyses were performed on G banded metaphases from leukocyte cultures. Excess of chromosomal material on the short arms in one of the chromosomes 5 was detected in the propositus. FISH (Fluorescence In Situ Hybridization) was carried out to identify the origin of the extra chromosomal material attached to 5p15. The extra chromosomal material was found to be derived from chromosome 13. The cytogenetic study of her father identified a translocation (5;13)(p15;q22) and the propositus' karyotype was redesigned as 46,XX,der(5)t(5;13)(p15;q22)pat (fig. 4A and 4B).
The majority of trisomy 13q cases (>91%) are maternal in origin and, similar to other autosomal trisomies, the extra chromosome is typically due to errors in meiosis I. Surprisingly, however, a large number of errors also occur during maternal meiosis II (approximately 37%), distinguishing trisomy 13 from other acrocentric and most nonacrocentric chromosomes. As other trisomies, failure to recombine is an important contributor to nondisjunction of chromosome 13 . Many cases arise from parental balanced translocations, sometimes from parental pericentric inversions and rarely from de novo duplications [10–12]. The presented case suffered a chromosomal unbalance with a partial trisomic component 13q22-qter and a monosomic component 5p15-pter from paternal origin. The length defect in chromosome 5 was short and the patient did not exhibit phenotypic features associated to deletions in 5pter, like cri du chat syndrome or speech disabilities, hence the material responsible for the phenotype changes is supposed to be the material extra in chromosome 13 . It is known that some chromosomal diseases show variability of phenotype. This patient, as some others previously reported cases with partial trisomy 13, had hypoacusia, hypochromic anaemia  or splenomegaly , but she did not have polydactyl  or characteristic eyelashes or ears . By contrast, she suffered leukoencephalopathy, minimal changes in sterols, early menopause and late onset generalized seizures.
The reduction of available cholesterol and total cholesterol in lymphocytes (both in the membrane and intracellular) provokes indirectly a reduction in the long chain of fatty acids. This may contribute to decrease of estradiol and subsequent early menopause.
Seizures in unbalanced trisomy of chromosome 13 have been described to occur at early age, but usually associated to structural lesions. In other chomosomopathies seizures are due to dysfunctional neuronal GABA transporters or another neurotransmition regulation [18, 19]. In previous reports no details are given on the type of seizure or EEG findings. In genetic leukodystrophy, clinical seizures are mainly of focal origin. At the beginning, the EEG is normal or shows mild slowing with progressive slowing and focal or multifocal paroxysmal discharges in later stages . By contrast, our patient showed atonic o myoclonic generalised seizures with normal background activity and generalised paroxysmal discharges on EEG. She had good response to valproic acid leading to normalization on follow-up EEGs.
The normal motor conduction speed and the normal long chain fatty acid in fibroblasts discard adrenoleukodystrophy. To date, the only gene described for leukoencephalopathy with vanishing white matter (VWM) codes for oligodendrocyte-specific protein (OSP) and is located on chromosome 3q27 . We do not know if the leukoencephalopathy changes in the MRI could be related to the lipidic deficit. Knoblauch H. et al.  described a cholesterol lowering gene localised in chromosome 13q. However, we think that our patient had other specific characteristics; she did not suffer familiar hypercholesterolemia or increase of LDL cholesterol.
Today, the diagnosis of leukoencephalopathies is more frequent because the use of neuroimaging represents an early diagnostic tool in clinical evaluation. Many cases have identifiable clinical, biochemical, molecular or neuroimaging markers. However identification and categorisation is still limited in a considerable number of cases by the lack of biological or genetic markers. Molecular techniques will facilitate the delineation of phenotypic variability and the understanding of the biological basis for future rational therapeutic interventions.
The presented case illustrates the phenotype of 13q22 in adult age at the time that reaffirm the importance of studying the karyotype of any patient with seizures who shows special clinical features including leukoencephalopathy, stroke at a young age, fatty acids disturbances, microcephaly, hypotelorism, short neck, hemangiomata, short fingers or distal swell in thumbs.
Written informed consent was obtained from the patient for publication of the case report and accompanying images.
Low Density Lipoprotein
Magnetic Resonance Imaging
Fluorescence In Situ Hybridization
No Rapid Eye Movement
Vanishing White Matter
Porter IJ: Chromosome 13 trisomy distal 13q. Birth defects Encyclopaedia. U.S.A. Dover Blackwell editorial (Edited by: Buyse M). 1991, 370–371.
Brewer CM, Holloway SH, Stone DH, Carothers AD, Fitz Patrick DR: Survival in trisomy 13 and trisomy 18 cases ascertained from population based registers. J Med Genet 2002,9(9):s54.
Sener RN: Bilateral perisylvian and rolandic cortical dysplasia in trisomy 13 syndrome. J Neuroradiol 1996, 23:231–233.
Yamanouchi H, Imataka G, Nakaagawa E, Nitta A, Suzuki N, Hirao J, Suzumura H, Watanabe H, Arisaka O, Eguchi M: An Analysis of epilepsy with chromosomal abnormalities. Brain Dev 2005, 27:370–377.
Torniero C, Zufardi O, Darra F, Dalla Bernardina B: Scotosensitive and photosensitive myoclonic seizures in an infant with trisomy 13. Epilepsia 2007, 48:2177–2180.
Nelson BP, Gupta R, Dewald GW, Paternoster SF, Rosen ST, Peterson LC: Chronic lymphocytic leukaemia FISH panel: impact on diagnosis. Am J Cin Pathol 2007, 128:323–332.
Bang SM, Kim YR, Cho HT, Chi HS, Seo EJ, Park CJ, Yoo SJ, Kim HC, Chung HG, Min HC, Oh BR, Kim TY, Lee JH, Lee DS: Identification of 13q delection, trisomy 1q and IgH reamangement as the most frequent chromosomal changes found in Korean patients with multiple myeloma. Cancer Genet Cytogenet 2006, 168:124–132.
Lukusa T, Berghe L, Sweets E, Fryns JP: Proximal trisomy 13q and distal monosomy 8p in a dysmorphic and mentally retarded patient with an isodicentric chromosome 13q and 13q8p translocation chromosome. Ann Genet 1999, 42:215–220.
Hall HE, Chan ER, Collins A, Judis L, Shirley S, Surti U, Hoffner L, Cockwell AE, Jacobs PA, Hassold TJ: The origin of trisomy 13. Am J Genet A 2007, 143:2242–2248.
Pangalas C, Couturier J: Partial trisomy 13 (q21.3 leads to qter) resulting from a maternal translocation t (24.31). Ann Genet 1981,24(3):179–181.
Rao VV, Carpenter NJ, Gucsavas M, Coldwll J, Say B: Partial trisomy 13q identified by sequential fluorescence in situ hybridization. Am J Med Genet 1995, 58:50–53.
Patil SJ, Phadke SR: Pericentric inversion causing duplication and deletion of chromosome region 13q22->qter in offspring. Am J Med Genet A 2007, 143:82–84.
Church DM, Bengtsson U, Nielsen KV, Wasmuth JJ, Niebuhr E: Molecular definition of deletions of different segments of distal 5p that result in distinct phenotypic features. Am J Hum Genet 1995,56(5):1162–1172.
Rivas F, Rivera H, Plascencia ML, Ibarra B, Cantú JM: The phenotype in partial 13q trisomies apropos of a familial (13:15) (q22q26) translocation. Hum Genet 1984, 67:86–93.
Yang XY, Heller DS, Baergen RN: Splenopancreatic field abnormality in trisomy 13 Pediatr. Dev Pathol 2002,5;(4):414–415.
Rodriguez de Alba M, Sanz R, Lorda-Sanchez , Fernández-Moya JM, Ayuso C, Diaz-Recasen J, Ramos C: Segregation of digital number with partial monosomy or trisomy of 13q in familial 5,13 translocation. Prenat Diagn 1999, 19:884–886.
Lin HY, Lin SP, Chen YJ, Hsu CH, Kao HA, Chen MR, Hung HY, Ho CS, Chang JH, Huang FY, Tsai TC, Lin DS, Chan WT: Clinical characteristics and survival of trisomy 13 in a medical center of Taiwan, 1985–2004. Pediatr Int 2007, 49:380–386.
Li LM, O'Donoghue MF, Sander JMAS: Myoclonic epilepsy of late onset in trisomy 21. Arq Neuropsiquiatr 1995,53(4):793–794.
Battaglia A, Guerrini R: Chromosomal disorders associated with epilepsy. Epileptic Disord 2005, 7:181–192.
Pen-Yung Wang, Whu-Liang Hwu, Yu-Sen Shen: Epileptic seizures and electroencephalographic evolution in genetic leukodystrophies. J Clin Neurophysiol 2001, 18:25–32.
Leegwater PA, Könst AA, Kuyt B, Sandkuijl LA, Naidu S, Oudejans CB, Shutgens RB, Pronk JC, Van der Knaap MS: The gene for leukoencephalopathy with vanishing white matter is located in chromosome 3q27. Am J Hum Genet 1999, 65:728–734.
Knoblauch H, Müller-Myhsok B, Busjahn A, Ben Avi L, Bähring S, Baron H, Heath SC, Uhlmann R, Faulhaber HD, Shpitzen S, Aydin A, Reshef A, Rosenthal M, Eliav O, Mühl A, Lowe A, Schurr D, Harats D, Jeschke E, Friedlander Y, Schuster H, Luft FC, Leitersdorf E: A cholesterol lowering gene map to chromosome 13q. Am J Hum Genet 2000, 66:157–166.
The authors declare that they have no competing interests.
RR described the phenotypic features and complementary tests findings of the case. MMG and JS contributed to the manuscript writing and discussion. I. Hernando performed the cytogenic and genomic analyses. M Giros performed the biochemical studies on lipids.
About this article
Cite this article
Ribacoba, R., Menendez-Gonzalez, M., Hernando, I. et al. Partial trisomy 13q22-qter associated to leukoencephalopathy and late onset generalised epilepsy. Int Arch Med 1, 5 (2008) doi:10.1186/1755-7682-1-5